Pro-Active: Comparing The Effectiveness Of Prophylactic Swallow Intervention For Patients Receiving Radiotherapy For Head And Neck Cancer
Posted Date: Sep 19, 2022
- Investigator: Brittany Krekeler
- Specialties: Head and Neck Cancer, Otolaryngology, Speech Pathology
- Type of Study: Observational/Survey
Swallowing therapy is commonly provided as a behavioural treatment to lessen the risk or severity of dysphagia in head and neck cancer (HNC) patients; however, best practice is not established. This multi-site, international randomized clinical trial (RCT) will compare the effectiveness of PRO-ACTIVE (high and low intensity) versus RE-ACTIVE swallowing interventions in 952 HNC patients undergoing radiotherapy (RT). The 3 study arms represent alternate timing and intensity of swallowing therapy delivered by a speech language pathologist: 1) RE-ACTIVE, 2) PRO-ACTIVE EAT, and 3) PRO-ACTIVE EAT + EXERCISE.
Criteria:
Adults (18 Years Or Older) Diagnosed With Head And Neck Malignancy Who Are Undergoing Radiation Therapy Treatment Planned For Curative Intent Who Will Receive External Beam Radiotherapy Dose Of At Least 60 Gray Bilaterally.
Keywords:
Swallowing, Head And Neck Cancer, Treatment
For More Information:
Brittany Krekeler
5132272759
krekelby@ucmail.uc.edu